tiprankstipranks
Advertisement
Advertisement

DRMA Stock Latest News

Dermata receives notice of acceptance of Australian patent application
The FlyDermata receives notice of acceptance of Australian patent application
11d ago
DRMA
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
PremiumThe Fly
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
12d ago
DRMA
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
PremiumThe Fly
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
1M ago
DRMA
Dermata Therapeutics announces release of Tome Skincare
PremiumThe Fly
Dermata Therapeutics announces release of Tome Skincare
1M ago
DRMA
Dermata Therapeutics Announces Board Resignation and Size Reduction
PremiumCompany Announcements
Dermata Therapeutics Announces Board Resignation and Size Reduction
2M ago
8K
DRMA
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
PremiumCompany AnnouncementsDermata Therapeutics Expands At-The-Market Equity Offering Capacity
3M ago
8K
DRMA
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
Premium
The Fly
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
3M ago
DRMA
Dermata Therapeutics receives notice of grant of patent for acne treatment
Premium
The Fly
Dermata Therapeutics receives notice of grant of patent for acne treatment
3M ago
DRMA
Dermata Therapeutics Raises Capital via December Private Placement
PremiumCompany Announcements
Dermata Therapeutics Raises Capital via December Private Placement
3M ago
8K
DRMA
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
PremiumThe Fly
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
4M ago
DRMA
Dermata Therapeutics to reveal brand name for OTC skincare business
PremiumThe Fly
Dermata Therapeutics to reveal brand name for OTC skincare business
4M ago
DRMA
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
PremiumRatings
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
5M ago
DRMA
Dermata Therapeutics files $100M mixed securities shelf
PremiumThe FlyDermata Therapeutics files $100M mixed securities shelf
5M ago
DRMA
Dermata Therapeutics Ends License Agreement with Villani
Premium
Company Announcements
Dermata Therapeutics Ends License Agreement with Villani
5M ago
8K
DRMA
Dermata Therapeutics Shifts Focus to OTC Skincare
Premium
Company Announcements
Dermata Therapeutics Shifts Focus to OTC Skincare
5M ago
8K
DRMA
Dermata Therapeutics Increases Stock Offering by $1.79M
PremiumCompany Announcements
Dermata Therapeutics Increases Stock Offering by $1.79M
5M ago
8K
DRMA
Dermata says Australian Patent Office accepts Spongilla tech application
PremiumThe Fly
Dermata says Australian Patent Office accepts Spongilla tech application
6M ago
DRMA
Dermata Therapeutics Presents Promising Phase 3 Trial Results
PremiumCompany Announcements
Dermata Therapeutics Presents Promising Phase 3 Trial Results
7M ago
8K
DRMA
Dermata Shifts Focus to Over-the-Counter Dermatology
PremiumCompany Announcements
Dermata Shifts Focus to Over-the-Counter Dermatology
7M ago
8K
DRMA
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
PremiumThe FlyDermata Therapeutics announces strategic pivot to OTC skin care treatments
7M ago
DRMA
Dermata Therapeutics withdraws IND application for XYNGARI
Premium
The Fly
Dermata Therapeutics withdraws IND application for XYNGARI
7M ago
DRMA
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
Premium
Company Announcements
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
8M ago
8K
DRMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >